These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 27292026
1. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer. Rojas A, Zhang P, Wang Y, Foo WC, Muñoz NM, Xiao L, Wang J, Gores GJ, Hung MC, Blechacz B. Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026 [Abstract] [Full Text] [Related]
2. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H. Carcinogenesis; 2018 Jul 03; 39(7):900-910. PubMed ID: 29365054 [Abstract] [Full Text] [Related]
3. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration. Wang B, Liu T, Wu JC, Luo SZ, Chen R, Lu LG, Xu MY. Biomed Pharmacother; 2018 Feb 03; 98():214-221. PubMed ID: 29268242 [Abstract] [Full Text] [Related]
4. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG. Hepatology; 2013 Oct 03; 58(4):1349-61. PubMed ID: 23696034 [Abstract] [Full Text] [Related]
5. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression. Zhang S, Sun WY, Wu JJ, Gu YJ, Wei W. Oncol Rep; 2016 Apr 03; 35(4):2373-81. PubMed ID: 26882862 [Abstract] [Full Text] [Related]
6. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma. Wang X, Dong J, Jia L, Zhao T, Lang M, Li Z, Lan C, Li X, Hao J, Wang H, Qin T, Huang C, Yang S, Yu M, Ren H. Cancer Lett; 2017 May 01; 393():113-124. PubMed ID: 28153790 [Abstract] [Full Text] [Related]
7. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma. Chen J, Zhu H, Liu Q, Ning D, Zhang Z, Zhang L, Mo J, Du P, Liu X, Song S, Fan Y, Liang H, Liu J, Zhang B, Chen X. J Exp Clin Cancer Res; 2019 Jun 22; 38(1):273. PubMed ID: 31228948 [Abstract] [Full Text] [Related]
8. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Ding ZY, Jin GN, Wang W, Chen WX, Wu YH, Ai X, Chen L, Zhang WG, Liang HF, Laurence A, Zhang MZ, Datta PK, Zhang B, Chen XP. Hepatology; 2014 Nov 22; 60(5):1620-36. PubMed ID: 24954480 [Abstract] [Full Text] [Related]
9. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells. Zhong M, Zhong C, Cui W, Wang G, Zheng G, Li L, Zhang J, Ren R, Gao H, Wang T, Li X, Che J, Gohda E. BMC Cancer; 2019 May 14; 19(1):439. PubMed ID: 31088527 [Abstract] [Full Text] [Related]
10. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma. Qin G, Luo M, Chen J, Dang Y, Chen G, Li L, Zeng J, Lu Y, Yang J. Cancer Lett; 2016 Apr 28; 374(1):85-95. PubMed ID: 26872724 [Abstract] [Full Text] [Related]
11. TGF-β1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression. Huang J, Qiu M, Wan L, Wang G, Huang T, Chen Z, Jiang S, Li X, Xie L, Cai L. Cell Physiol Biochem; 2018 Apr 28; 45(4):1690-1699. PubMed ID: 29490293 [Abstract] [Full Text] [Related]
12. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop. Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang Y, Feng T, Wu J, Liu X. Oncotarget; 2016 Sep 27; 7(39):63324-63337. PubMed ID: 27556509 [Abstract] [Full Text] [Related]
13. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression. Ali A, Zhang P, Liangfang Y, Wenshe S, Wang H, Lin X, Dai Y, Feng XH, Moses R, Wang D, Li X, Xiao J. Cell Death Dis; 2015 Mar 12; 6(3):e1681. PubMed ID: 25766320 [Abstract] [Full Text] [Related]
14. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C, Guo F, Xu G, Ma J, Shao F. Oncol Rep; 2015 Apr 12; 33(4):1872-82. PubMed ID: 25653024 [Abstract] [Full Text] [Related]
15. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling. Yang G, Liang Y, Zheng T, Song R, Wang J, Shi H, Sun B, Xie C, Li Y, Han J, Pan S, Lan Y, Liu X, Zhu M, Wang Y, Liu L. Cancer Lett; 2016 Aug 10; 378(2):80-6. PubMed ID: 27177473 [Abstract] [Full Text] [Related]
16. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway. Wang J, Fan Z, Li J, Yang J, Liu X, Cheng J. Bioengineered; 2021 Dec 10; 12(1):3566-3577. PubMed ID: 34281492 [Abstract] [Full Text] [Related]
20. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao WH, Liu XY, Wang Y, Yang ZC, Xu HM, Wang HB. Oncol Rep; 2013 Jan 28; 29(1):219-25. PubMed ID: 23129177 [Abstract] [Full Text] [Related] Page: [Next] [New Search]